Starting a new medication always comes with questions, and ketamine tablets are no exception. Because ketamine works differently from traditional antidepressants, the experience of taking it can feel unfamiliar. This guide walks you through what to expect physically and mentally, from your very first dose through the first month and beyond.
Before Your First Dose
Your prescribing clinician will typically provide specific instructions, but most protocols share common preparation steps. You will be advised to fast for two to four hours before taking the tablet to reduce nausea and improve absorption. Arrange for a quiet, comfortable space where you can remain for two to three hours. You should not plan to drive, operate machinery, or make important decisions for the remainder of the day after dosing.
Have water, a blanket, and a calm playlist or ambient sounds ready. Many patients find that an eye mask helps them relax during the experience. Make sure someone knows you are dosing, even if they are not in the same room, so help is available if needed.
Your First Dose: What Happens in the First Hour
After placing the ketamine tablet under your tongue, you will hold it there as it dissolves. This process typically takes 10 to 20 minutes. The taste is often described as bitter or medicinal, and some patients notice a mild numbing sensation in the mouth and tongue. Avoid swallowing the saliva too quickly, as sublingual absorption is what delivers the medication effectively.
0 to 15 Minutes
During the first few minutes, most patients feel nothing unusual. The tablet is dissolving and the medication is beginning to absorb through the tissues under the tongue. Some people report a slight tingling or numbness in the mouth.
15 to 30 Minutes
This is when most patients begin to notice the first effects. Common early sensations include:
- A feeling of lightness or heaviness in the limbs
- Mild dizziness or a floating sensation
- Slight changes in how sounds or light are perceived
- A sense that time is moving differently, either slower or faster
These effects are normal and expected. They are signs that the ketamine is reaching your brain and beginning to interact with NMDA receptors, the primary target of ketamine's antidepressant mechanism.
30 to 60 Minutes
The peak of the experience usually arrives between 30 and 60 minutes after the tablet begins dissolving. During the peak, patients commonly describe:
- Dissociation: A sense of being slightly separated from your body or surroundings. This can range from mild detachment to a more pronounced feeling of observing yourself from a distance. At therapeutic doses, this is typically gentle and manageable.
- Visual changes: Patterns may appear more vivid, or you might see subtle geometric shapes with your eyes closed. Some patients describe colors appearing more saturated.
- Emotional shifts: Some people feel a wave of calm or relief. Others experience unexpected emotions surfacing, such as sadness or nostalgia. Both responses are considered normal.
- Physical sensations: Warmth spreading through the body, heaviness in the arms and legs, or a sense of gentle rocking or swaying.
- Nausea: Mild nausea affects some patients, particularly during the first few sessions. This usually passes within 15 to 20 minutes. Your clinician may recommend an anti-nausea medication if this is persistent.
It is important to remember that the intensity of these effects varies significantly between individuals and is dose-dependent. Your clinician will typically start you at a lower dose and adjust upward gradually.
The Comedown: 60 to 120 Minutes
After the peak, effects gradually taper. The dissociative sensations fade first, followed by the physical heaviness. Most patients describe this phase as a gentle return to normal awareness, similar to slowly waking from a deep rest. You may feel:
- Slightly groggy or mentally soft
- Unusually relaxed
- Mildly fatigued
- Emotionally open or reflective
This is a good time to rest quietly, journal, or simply sit with your thoughts. Many patients find the period immediately after the peak to be when meaningful reflections or insights emerge.
By the two-hour mark, most acute effects have resolved. However, you should not drive or engage in activities requiring sharp focus for the rest of the day.
Week One: The Adjustment Period
During your first week of treatment, which typically involves one to three dosing sessions depending on your protocol, the experience is primarily about your body adjusting to the medication.
What to expect:
- Each session may feel slightly different. The second or third dose often produces less anxiety than the first because you know what to expect.
- Nausea, if present during the first session, often decreases with subsequent doses.
- You may or may not notice mood changes yet. Some patients report feeling lighter or more hopeful within the first few days, while others notice no change this early.
- Sleep patterns may shift. Some patients sleep more deeply in the days following a dose; others experience mild restlessness the first night.
- You might feel emotionally sensitive or more aware of your feelings between sessions. This is a common and generally positive sign that neuroplastic changes are beginning.
What is normal:
- Not feeling a dramatic difference yet
- Mild headache after a session
- Increased dream vividness
- Feeling tired the evening after a dose
Week Two: Early Signs of Change
By the second week, patients who are responding to treatment often begin to notice subtle but meaningful shifts. These rarely arrive as a single dramatic moment. Instead, they tend to appear as small changes in daily life:
- Negative thought loops may feel less sticky or less automatic
- Motivation for small tasks may increase slightly
- Social interactions might feel less draining
- Sleep quality may improve
- You may catch yourself feeling moments of interest or pleasure that have been absent
The dissociative effects during sessions often feel more familiar and less disorienting by this point. Some patients describe developing a kind of comfort with the experience, learning to relax into it rather than resist it.
If you have not noticed any changes by the end of week two, this does not mean the treatment has failed. Response timelines vary, and your clinician may consider dose adjustments.
Week Three: Building Momentum
For many patients, week three is when the benefits become more consistent and recognizable. The neuroplastic effects of ketamine, including increased synaptic connectivity and enhanced brain-derived neurotrophic factor (BDNF) activity, are cumulative. Research published in the American Journal of Psychiatry suggests that repeated ketamine exposures build on each other to strengthen new neural pathways.
Common week-three experiences include:
- A more stable sense of improved mood between sessions
- Greater emotional resilience when stressors arise
- Improved ability to engage with therapy or self-reflection
- Physical side effects during sessions continuing to diminish
- A clearer sense of whether the current dose is appropriate
Some patients describe this phase as the point where they start to feel like themselves again, or where the fog begins to lift in a sustained way.
Week Four and Beyond: Maintenance and Long-Term Expectations
By week four, most treatment protocols transition from an initial intensive phase to a maintenance schedule. Dosing frequency is often reduced from multiple times per week to once weekly, biweekly, or as needed based on symptom monitoring.
What ongoing treatment typically looks like:
- Sessions become routine and the experience feels predictable
- The intensity of dissociative effects may remain stable or decrease slightly over time
- Mood benefits between sessions become the focus rather than the in-session experience
- You and your clinician will work together to find the minimum effective dose and frequency
- Some patients maintain benefits with sessions every two to four weeks; others need weekly dosing
Important long-term considerations:
- Ketamine is most effective when combined with therapy, lifestyle changes, and other evidence-based supports
- Tolerance can develop, meaning the same dose may feel less intense over time. This does not necessarily mean it is less effective for mood, but it should be discussed with your clinician
- Periodic breaks from treatment may be recommended to assess baseline mood and manage tolerance
- Urinary and bladder health should be monitored with long-term use, as high-frequency or high-dose ketamine has been associated with urinary tract effects in some studies
When to Contact Your Clinician
While most side effects are mild and transient, reach out to your prescribing clinician if you experience:
- Severe or persistent nausea and vomiting
- Panic or extreme anxiety during a session that does not resolve
- Urinary pain, frequency, or blood in urine
- Worsening depression or suicidal thoughts between sessions
- Effects that feel significantly more intense than previous sessions at the same dose
- Any symptoms that feel concerning or unexpected
What Ketamine Tablets Do Not Feel Like
It can be helpful to address common misconceptions. At therapeutic doses prescribed for depression or anxiety, ketamine tablets do not typically produce:
- Complete loss of consciousness
- Hallucinations comparable to psychedelic substances at high doses
- Euphoria or a recreational high (mild pleasant feelings are possible, but the clinical experience is distinct from recreational use)
- Immediate or total elimination of depression symptoms
The clinical experience is intentionally calibrated to be therapeutic, not overwhelming. Your clinician adjusts the dose to produce sufficient neurobiological effect while keeping the experience manageable and safe.
Summary
Starting ketamine tablets is a process that unfolds over weeks, not hours. The first dose introduces you to the unique physical and mental sensations of the medication. Over the following weeks, your body adjusts, side effects typically diminish, and therapeutic benefits build progressively. Working closely with your clinician to track your response and adjust dosing is the most important factor in a successful treatment course.
References
- Ketamine for Treatment-Resistant Depression: Recent Developments and Clinical Considerations — Review of ketamine's antidepressant mechanisms including NMDA receptor modulation and BDNF signaling, published in Evidence-Based Mental Health.
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders — American Psychiatric Association consensus on ketamine prescribing, dosing protocols, and expected patient experiences.
- Sublingual and Oral Ketamine for Depression: A Systematic Review — Systematic review of oral and sublingual ketamine efficacy, bioavailability, and patient-reported outcomes.
Share